Figure S1. (A) Quantitative Real time-PCR validation of relative miR-211 expression levels in normal human melanocytes and melanoma cell lines used in this study. (B) Melanoblasts (MB) from two different neonate foreskins (Donors 2 & 3) were independently differentiated into melanocytes (MB:MC) as previously described (Cook et al., 2003), before determination of BRN2, MITFand TRPM1 levels.

Figure S2. Relative miR-211 expression levels following lentiviral transduction to generate polyclonal cell lines.

Figure S3. Potential miR-211 binding sites in the BRN2 3’UTR are conserved across species.

Figure S4. Mutation of Site 3 results in a fairly minimal derepression of the BRN2 3’ UTR reporter.

Figure S5. Diagram showing the human BRN2 3’UTR.

Table S1. Summary of predicted miR-211 & miR-204 targets: source of prediction, miRNA binding site information, method of validation attempted.

Table S2. Local free energy scores in BRN2 mRNA for potential miR-211 binding sites.

PCMR_849_sm_fs1.tif23643KSupporting info item
PCMR_849_sm_fs2.tif10519KSupporting info item
PCMR_849_sm_fs3.tif367KSupporting info item
PCMR_849_sm_fs4.tif13966KSupporting info item
PCMR_849_sm_fs5.tif311KSupporting info item
PCMR_849_sm_tables1.doc56KSupporting info item
PCMR_849_sm_tables2.doc29KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.